Corbus Pharmaceuticals Holdings (CRBP) Other financing activities (2015 - 2017)

Corbus Pharmaceuticals Holdings has reported Other financing activities for 3 years, with the latest figure at $80248.0 in Q1 2017.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $80248.0 in Q1 2017; TTM through Mar 2017 was $6.7 million, a N/A change from a year earlier, with the FY2015 full-year figure at $10.8 million, changed N/A from the prior year.
• Other financing activities was $80248.0 for Q1 2017 at Corbus Pharmaceuticals Holdings, down from $179443.0 in the prior quarter.
• The five-year high for Other financing activities was $6.4 million in Q3 2015, with the low at $80248.0 in Q1 2017.
• Average Other financing activities over 3 years is $2.2 million, with a median of $179443.0 recorded in 2016.
• The largest YoY upside for Other financing activities was 97.2% in 2016 against a maximum downside of 97.2% in 2016.
• Over 3 years, Other financing activities stood at $6.4 million in 2015, then slumped by 97.2% to $179443.0 in 2016, then slumped by 55.28% to $80248.0 in 2017.
• The last three Other financing activities figures came in at $80248.0 (Q1 2017), $179443.0 (Q3 2016), and $6.4 million (Q3 2015), per Business Quant data.